You have 9 free searches left this month | for more free features.

Ophthalmic Solutions

Showing 2601 - 2625 of 2,869

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Assessment of Motivity Trial in Nice (go-cart)

Unknown status
  • Assessment of Motivity
  • go-cart
  • Nice, France
    Centre Mémoire de Ressources et de Recherche
Oct 12, 2012

Concerns About Falling, Aged Trial in Maastricht (an in-home cognitive behavioral program)

Completed
  • Concerns About Falling
  • Aged
  • an in-home cognitive behavioral program
  • Maastricht, Netherlands
    Maastricht University
Jul 9, 2012

Allergic Conjunctivitis Trial in United States (R89674 0.025% ophthalmic solution)

Completed
  • Allergic Conjunctivitis
  • R89674 0.025% ophthalmic solution
  • Louisville, Kentucky
  • +5 more
Sep 26, 2011

Dry Eye Disease Trial in United States (Azithromycin Ophthalmic Solution, 1%, Placebo)

Completed
  • Dry Eye Disease
  • Azithromycin Ophthalmic Solution, 1%
  • Placebo
  • Artesia, California
  • +8 more
Sep 20, 2011

Anti-biotic Resistance Trial in Minneapolis, Saskatoon (moxifloxacin 0.5% HCI ophthalmic solution, gatifloxacin ophthalmic

Completed
  • Anti-biotic Resistance
  • moxifloxacin 0.5% HCI ophthalmic solution
  • gatifloxacin ophthalmic solution 0.3%
  • Minneapolis, Minnesota
  • +1 more
Nov 16, 2011

Healthy Trial in Rennes (20% amylose bread, 10% amylose bread, Carbohydrates)

Completed
  • Healthy
  • 20% amylose bread
  • +2 more
  • Rennes, Bretagne, France
    Rennes University Hospital
May 15, 2012

Blepharitis Trial in United States (Azithromycin ophthalmic solution, 1%, Placebo)

Completed
  • Blepharitis
  • Azithromycin ophthalmic solution, 1%
  • Placebo
  • Little Rock, Arkansas
  • +32 more
Sep 20, 2011

Healthy Trial in Heidelberg (Povidone K25 eye drops (povidone))

Completed
  • Healthy
  • Povidone K25 eye drops (povidone)
  • Heidelberg, Germany
    Novartis Investigational Site
Nov 16, 2011

Type 2 Diabetes Trial in Toronto (oat beta-glucan, Placebo)

Completed
  • Type 2 Diabetes
  • oat beta-glucan
  • Placebo
  • Toronto, Ontario, Canada
    GILabs
Jun 1, 2012

Seasonal Allergic Conjunctivitis Trial in Singapore (Loteprednol etabonate 0.2%, Olopatadine 0.1%)

Completed
  • Seasonal Allergic Conjunctivitis
  • Loteprednol etabonate 0.2%
  • Olopatadine 0.1%
  • Singapore, Singapore
    Bausch & Lomb Singapore
Feb 17, 2012

Allergic Conjunctivitis Trial in Rochester (Loteprednol etabonate base (QD), Loteprednol etabonate base (BID), Loteprednol

Completed
  • Allergic Conjunctivitis
  • Loteprednol etabonate base (QD)
  • +4 more
  • Rochester, New York
    Bausch & Lomb
Feb 14, 2012

Anxiety, Pain Trial in Qazvin (Melatonin, Gabapentin, )

Completed
  • Anxiety
  • Pain
  • Qazvin, Iran, Islamic Republic of
    Qazvin university of medical science
Oct 10, 2012

Allergic Rhinitis, Allergic Conjunctivitis Trial in Mississauga (Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops,

Completed
  • Allergic Rhinitis
  • Allergic Conjunctivitis
  • Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops
  • Placebo
  • Mississauga, Ontario, Canada
    Cetero Research
Nov 18, 2011

Conjunctivitis, Keratitis, Blepharitis Trial in Singapore (Loteprednol and tobramycin, Tobramycin and dexamethasone)

Completed
  • Conjunctivitis
  • +2 more
  • Loteprednol and tobramycin
  • Tobramycin and dexamethasone
  • Singapore, Singapore
    Bausch & Lomb Inc
Feb 27, 2012

Radiation Retinopathy, Choroidal Melanoma Trial in New York (Ranibizumab, ranibizumab)

Completed
  • Radiation Retinopathy
  • Choroidal Melanoma
  • New York, New York
    The New York Eye Cancer Center
Apr 25, 2012

Human Umbilical Vein Endothelial Cells (HUVEC)-Perfusion

Unknown status
  • Thrombosis
  • +2 more
    • Vienna, Austria
      Medical University Vienna- Dept. of Clinical Pharmacology
    Apr 22, 2012

    Violence, Juvenile Delinquency, Social Problems Trial in Ann Arbor (Youth Empowerment Solutions for Peaceful Communities)

    Completed
    • Violence
    • +3 more
    • Youth Empowerment Solutions for Peaceful Communities
    • Ann Arbor, Michigan
      University of Michigan School of Public Health
    Apr 4, 2012

    Corneal Health, Cataract Surgery Trial in St. Louis (besivance, vigamox)

    Completed
    • Corneal Health
    • Cataract Surgery
    • St. Louis, Missouri
    • +1 more
    Oct 18, 2011

    Allergic Conjunctivitis Trial in Andover (Vehicle, Brimonidine Tartrate 0.01%, Brimonidine Tartrate 0.025%)

    Completed
    • Allergic Conjunctivitis
    • Andover, Massachusetts
      Ora, Inc.
    Mar 2, 2012

    Bacterial Conjunctivitis Trial in Rochester (Besifloxacin, Vehicle (Placebo))

    Completed
    • Bacterial Conjunctivitis
    • Rochester, New York
      Bausch & Lomb Incorporated
    Feb 14, 2012

    Allergic Conjunctivitis Trial (Olopatadine 0.1%, Tranilast 0.5%, Placebo (Olopatadine))

    Completed
    • Allergic Conjunctivitis
    • Olopatadine 0.1%
    • +3 more
    • (no location specified)
    May 29, 2012

    Hypotrichosis Trial in Philadelphia (bimatoprost ophthalmic 0.03% solution, vehicle sterile solution ())

    Completed
    • Hypotrichosis
    • bimatoprost ophthalmic 0.03% solution
    • vehicle sterile solution (placebo)
    • Philadelphia, Pennsylvania
      (unnamed)
    Nov 30, 2011

    Coronary Artery Stenosis Trial in Saint-etienne (St Thomas, Custodiol)

    Completed
    • Coronary Artery Stenosis
    • Saint-etienne, France
      CHU de Saint-Eienne
    Mar 16, 2012

    Myocardial Injury Trial in Ankara (HTK solution, crystalloid cardioplegia solution)

    Unknown status
    • Myocardial Injury
    • HTK solution
    • crystalloid cardioplegia solution
    • Ankara, Çankaya, Turkey
      Baskent University, Faculty of Medicine
    Mar 6, 2012

    Eye Diseases Trial in Fort Worth (Next Generation Ophthalmic Irrigating Solution (NGOIS), BSS Plus)

    Completed
    • Eye Diseases
    • Next Generation Ophthalmic Irrigating Solution (NGOIS)
    • BSS Plus
    • Fort Worth, Texas
      United States
    Mar 1, 2012